Effects on Satisfaction and Service Engagement of Paliperidone Palmitate Compared with Oral Paliperidone in Patients with Schizophrenia: An Open Label Randomized Controlled Trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects on Satisfaction and Service Engagement of Paliperidone Palmitate Compared with Oral Paliperidone in Patients with Schizophrenia: An Open Label Randomized Controlled Trial
Authors
Keywords
-
Journal
CLINICAL DRUG INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-12-06
DOI
10.1007/s40261-018-0734-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders
- (2018) Robin Emsley et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation
- (2017) M. C. Mauri et al. Expert Opinion On Drug Safety
- Paliperidone palmitate once-monthly maintains improvement in functioning domains of the Personal and Social Performance scale compared with placebo in subjects with schizoaffective disorder
- (2017) Dong-Jing Fu et al. SCHIZOPHRENIA RESEARCH
- Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
- (2016) Yoshiteru Takekita et al. BMC Psychiatry
- Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia
- (2016) Eduard Parellada et al. CNS DRUGS
- The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study
- (2016) Alessandro Rossi et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- LAI versus oral: A case-control study on subjective experience of antipsychotic maintenance treatment
- (2016) F. Pietrini et al. EUROPEAN PSYCHIATRY
- Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia
- (2016) L Hargarter et al. EXPERT OPINION ON PHARMACOTHERAPY
- Benefit–risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia
- (2016) Bennett Levitan et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study
- (2016) Andreas Schreiner et al. PSYCHOPHARMACOLOGY
- Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study
- (2016) John J. Isitt et al. SCHIZOPHRENIA RESEARCH
- Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia
- (2015) Georgia L. Stevens et al. Early Intervention in Psychiatry
- Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics
- (2015) Jun Soo Kwon et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and tolerability of paliperidone ER in patients with unsatisfactorily controlled schizophrenia by other antipsychotics
- (2015) Mauro Mauri et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics
- (2015) Ludger Hargarter et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia
- (2015) Andreas Schreiner et al. SCHIZOPHRENIA RESEARCH
- Poster #S83 PALIPERIDONE ER TREATMENT AND THE IMPROVEMENT OF SOCIAL AND COGNITIVE FUNCTION IN PATIENTS WITH SCHIZOPHRENICS – A 24-WEEK, SINGLE ARM, OPEN-LABEL STUDY
- (2014) Chuan Shi et al. SCHIZOPHRENIA RESEARCH
- Long-acting injectable risperidone and oral antipsychotics in patients with schizophrenia: results from a prospective, 1-year, non-interventional study (InORS)
- (2014) Andreas Schreiner et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia
- (2013) A. George Awad et al. CNS DRUGS
- Comparison of attitudes toward long-acting injectable antipsychotics among psychiatrists and patients
- (2013) Sung-Wan Kim et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry
- (2013) John M. Kane et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Myth of Schizophrenia as a Progressive Brain Disease
- (2012) Robert B. Zipursky et al. SCHIZOPHRENIA BULLETIN
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials
- (2011) Claudia Leucht et al. SCHIZOPHRENIA RESEARCH
- Treatment adherence therapy in people with psychotic disorders: randomised controlled trial
- (2010) A. B. P. Staring et al. BRITISH JOURNAL OF PSYCHIATRY
- Tolerability of paliperidone: a meta-analysis of randomized, controlled trials
- (2010) Catherine A. Harrington et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia
- (2010) S Gopal et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Recovery from schizophrenia and the recovery model
- (2009) Richard Warner CURRENT OPINION IN PSYCHIATRY
- Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia
- (2009) Dawn I. Velligan et al. PSYCHIATRY RESEARCH
- Comparison of Patient and Clinician Perspectives in the Assessment of Antipsychotic Medication Adherence
- (2009) Corrado Barbui et al. PSYCHOPATHOLOGY
- Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
- (2009) David Hough et al. SCHIZOPHRENIA RESEARCH
- Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia
- (2008) S. Mohamed et al. SCHIZOPHRENIA BULLETIN
- Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month Open-Label Extension
- (2007) Andreas Tzimos et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started